Takeda names new President of Europe and Canada Business Unit

pharmafile | March 31, 2017 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment 

Takeda has named Giles Platford as its new President of Europe and Canada (EUCAN) Business Unit as of 1 April, where he will head up operations in the region and report directly to Takeda President and CEO Christophe Weber.

Joining the company in 2009, Platford boasts over 15 years’ experience in the industry and has served in a range of roles for his current company, namely President of Emerging Markets, overseeing Russia-CIS, Latin America, Middle East-Africa, China and Asia Pacific (excluding Japan) where he led the design and implementation of the company’s Global Access to Medicines Programme.

Earlier, he served Takeda as General Manager in Brazil. He currently also holds the responsibility of Corporate Officer and member of the company’s Executive Team.

“EUCAN has been a high performing region in the last few years, and I am fully confident that Giles, with his solid business ability and understanding of Takeda values, is the ideal choice to lead this business unit” said Takeda President and CEO Christophe Weber. “His proven track record with the company in senior leadership roles across diverse geographies and cultures will no doubt bring a unique perspective and value to all facets of Takeda business in Europe and Canada.”

Related Content


Myeloma UK reveals new Director of Research appointment

UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …


Abbott CEO to step down after 21 years

After more than two decades at the head of the company, it has emerged that …


Lonza CEO to step down in 2020

It has been announced that Marc Funk, Chief Executive Officer at Lonza, is set to …

Latest content